- Half Year 2024 Healius Ltd Earnings Call TranscriptFeb 27, 2024A$1.27 (-8.66%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptNov 28, 2023
- Healius Ltd Conference Call TranscriptNov 22, 2023
- Full Year 2023 Healius Ltd Earnings Call TranscriptAug 30, 2023A$2.7 (+7.75%)Earnings
- Australian Clinical Labs Ltd To Merge with Healius Ltd Call TranscriptMar 19, 2023
- Half Year 2023 Healius Ltd Earnings Call TranscriptFeb 27, 2023A$2.6 (-4.10%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptOct 20, 2022
- Full Year 2022 Healius Ltd Earnings Call TranscriptAug 30, 2022A$3.54 (+3.51%)Earnings
- Half Year 2022 Healius Ltd Earnings Call TranscriptFeb 23, 2022A$4.08 (+5.25%)Earnings
- Healius Ltd to Acquire Agilex Biolabs Pty Ltd Call TranscriptDec 17, 2021
- Full Year 2021 Healius Ltd Earnings Call TranscriptAug 30, 2021A$4.32 (-7.34%)Earnings
- Half Year 2021 Healius Ltd Earnings Call TranscriptFeb 24, 2021A$3.69 (+2.31%)Earnings
- Healius Ltd Sustainable Improvements Program and Capital Management Plans Call TranscriptDec 08, 2020
- Healius Ltd Annual Shareholders Meeting TranscriptOct 22, 2020
- Full Year 2020 Healius Ltd Earnings Call TranscriptAug 21, 2020A$3.04 (+0.31%)Earnings
- Healius Ltd Sales of Medical Centres and Market Update Presentation TranscriptJun 15, 2020
- Half Year 2020 Healius Ltd Earnings Call TranscriptFeb 26, 2020A$2.94 (+15.22%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptNov 24, 2019
- Full Year 2019 Healius Ltd Earnings Call TranscriptAug 16, 2019A$2.71 (+5.02%)Earnings
Half Year 2020 Healius Ltd Earnings Call Transcript
(technical difficulty)
Thank you, Janet. Thank you all for joining our first half results call today. First, as you will have seen today, we have received an unsolicited and nonbinding indicative offer from Partners Group for Healius. Partners Group have also announced that they have acquired a relevant interest in Jangho's 16% stake. Now we can't make any comment at this early stage. But of course, the Board will undertake their assessment in due course, and we will certainly keep the market informed as we go.
So turning to the first half overview and turning to our results, let me reiterate that our strategic review last year identified the best opportunities for long-term growth and for portfolio simplification to drive shareholder value. We have a clear view of where we are heading with our strategy. And as part of this, we'd like to confirm that we intend to explore a sale process for part or all of the Medical Centre
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)